- Trials with a EudraCT protocol (478)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
478 result(s) found for: Cardiac volume.
Displaying page 1 of 24.
EudraCT Number: 2015-004485-28 | Sponsor Protocol Number: 38RC15.214 | Start Date*: 2016-01-18 | |||||||||||
Sponsor Name:Centre Hospitalier Universitaire de Grenoble | |||||||||||||
Full Title: | |||||||||||||
Medical condition: Patients should be operated for cardiac surgery with cardiac bypass and in sinus rhythm, and for which the fact of the existence of impaired left ventricular function or the heaviness of the surgic... | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002455-26 | Sponsor Protocol Number: IRON-CMR | Start Date*: 2014-09-20 |
Sponsor Name:Karolinska Institute | ||
Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging. | ||
Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012372-27 | Sponsor Protocol Number: 200901 | Start Date*: 2009-09-17 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: The Sevoflurane study, understanding the effects of Sevoflurane to improve safety and outcome of cardiac surgery | |||||||||||||
Medical condition: myocardial ischemia reperfusion injury during cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001560-19 | Sponsor Protocol Number: CSCC-ASC2 | Start Date*: 2015-06-29 | |||||||||||
Sponsor Name:Department of Cardiology, Rigshospitalet | |||||||||||||
Full Title: Allogeneic adipose tissue-derived stromal/stem cell therapy in patients with ischemic heart disease and heart failure | |||||||||||||
Medical condition: Ischemic heart disease and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002367-34 | Sponsor Protocol Number: 29052016 | Start Date*: 2016-09-30 | |||||||||||
Sponsor Name:Hjertemedicinsk klinik, Rigshospitalet | |||||||||||||
Full Title: Beta 3 agonist treatment in heart failure (BEAT-HF II) | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001623-44 | Sponsor Protocol Number: IRON-CRT-001 | Start Date*: 2017-06-15 | |||||||||||
Sponsor Name:Ziekenhuis Oost Limburg (ZOL), Genk | |||||||||||||
Full Title: Effect of Intravenous Ferric Carboxymaltose on reverse remodeling following Cardiac Resynchronization therapy | |||||||||||||
Medical condition: Heart failure with reduced left ventricular ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004805-29 | Sponsor Protocol Number: 201200480529 | Start Date*: 2013-06-04 | |||||||||||
Sponsor Name:The Heart Center, Rigshospitalet | |||||||||||||
Full Title: Beta 3 agonist treatment in heart failure (BEAT-HF) | |||||||||||||
Medical condition: Systolic heart failure | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005077-39 | Sponsor Protocol Number: BBLOQ-2017 | Start Date*: 2018-06-12 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria INCLIVA | |||||||||||||
Full Title: Betablockers Withdrawal in Patients with Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence: Effect on Functional Capacity and life quality | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004938-11 | Sponsor Protocol Number: PI-GR-21-2386 | Start Date*: 2021-12-21 |
Sponsor Name:Hospital Clínico Universitario de Valladolid | ||
Full Title: Prevention of cardiac surgery-associated acute kidney injury through the use of sodium-glucose cotransporter 2 inhibitors | ||
Medical condition: Cardiac surgery-associated acute kidney injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002929-19 | Sponsor Protocol Number: SCIENCE | Start Date*: 2017-01-17 | |||||||||||
Sponsor Name:Department of Cardiology, Rigshospitalet | |||||||||||||
Full Title: Stem Cell therapy in IschEmic Non-treatable Cardiac disease - SCIENCE | |||||||||||||
Medical condition: Ischemic heart disease and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) DK (Completed) SI (Completed) DE (Completed) AT (Ongoing) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003111-28 | Sponsor Protocol Number: REPO-HFpEF-II | Start Date*: 2023-02-15 | |||||||||||
Sponsor Name:Hospital Clínico Universitario de Valencia | |||||||||||||
Full Title: Mechanism-based drug REpurPOsing in a subtype of Heart Failure with Preserved Ejection Fraction (REPO-HFPEF) | |||||||||||||
Medical condition: Subtype of Heart Failure with Preserved Ejection Fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004054-24 | Sponsor Protocol Number: PHRCN2017/CAPRI-MARIE/NK | Start Date*: 2019-03-18 | |||||||||||
Sponsor Name:Centre Hospitalier Régional Universitaire de Nancy | |||||||||||||
Full Title: Assessment of the (18)F-florbetaben whole-body PET imaging diagnostic performance for the detection of cardiac and extracardiac sites of amyloid deposits in patients with amyloidosis | |||||||||||||
Medical condition: cardiac amyloidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000805-27 | Sponsor Protocol Number: MEIN/10/Ran-Did/001 | Start Date*: 2012-10-23 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg | |||||||||||||
Full Title: Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction | |||||||||||||
Medical condition: Heart failure patients with preserved ejection fraction (HFpEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003968-39 | Sponsor Protocol Number: 2015CA02 | Start Date*: 2017-09-19 | ||||||||||||||||||||||||||
Sponsor Name:University of Dundee/NHS Tayside | ||||||||||||||||||||||||||||
Full Title: Renal and Cardiovascular Effects of SGLT2 inhibition in combination with loop diuretics in diabetic patients with chronic heart failure. | ||||||||||||||||||||||||||||
Medical condition: Type 2 diabetes and heart failure | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022679-71 | Sponsor Protocol Number: Xenon-MTH-Studie | Start Date*: 2011-01-07 | |||||||||||
Sponsor Name:Clinical Trials Center Aachen, University of Aachen | |||||||||||||
Full Title: Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation | |||||||||||||
Medical condition: In this clinical trial will be checked, whether 2 hours ventilation with xenon has neuroprotetctive effect on the patients, which had out of hospital cardiac arrest and successful cardiopulmonary r... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003088-87 | Sponsor Protocol Number: WWU20_0016 | Start Date*: 2021-11-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Westfälische Wilhelms-Universität Münster | |||||||||||||||||||||||||||||||||
Full Title: Biomarker-guided implementation of angiotensin-II (AT-II) to reduce the occurrence of kidney damage after cardiac surgery | |||||||||||||||||||||||||||||||||
Medical condition: Cardiac surgical patients at high risk for AKI | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003047-32 | Sponsor Protocol Number: IRFMN-7557 | Start Date*: 2021-01-21 | |||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | |||||||||||||
Full Title: CardioPulmonary resuscitation with Argon (CPAr) trial | |||||||||||||
Medical condition: Cardiac Arrest | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002020-25 | Sponsor Protocol Number: 052017 | Start Date*: 2018-08-31 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: ANGIOTENSIN–NEPRILYSIN INHIBITION IN DIASTOLIC DYSFUNCTION AFTER AMI | |||||||||||||
Medical condition: Diastolic dysfunction after acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002873-80 | Sponsor Protocol Number: AMILCA-DIFLU | Start Date*: 2020-01-14 |
Sponsor Name:FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE | ||
Full Title: Unicentre, open, uncontrolled clinical trial to assess the morphological, biochemical and functional effects of Diflunisal treatment in patients with transthyretin cardiac amyloidosis | ||
Medical condition: transthyretin cardiac amyloidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-008354-23 | Sponsor Protocol Number: ECAL-CCPB-08-07 | Start Date*: 2009-04-30 |
Sponsor Name:Cubist Pharmaceuticals,INC | ||
Full Title: CONSERVTM – 2 (Clinical Outcomes and Safety Trial to Investigate Ecallantide’s Effect on Reducing Surgical Blood Loss Volume) – A Phase 2 Randomized Double-Blind Active-Controlled Study in Subjects... | ||
Medical condition: Reduction of blood loss in subjects exposed to CPB during cardiac surgery at high risk for bleeding | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Completed) DE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
